Daewoong Pharma Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Daewoong Pharma - Alpha Spread

Daewoong Pharma
KRX:069620

Watchlist Manager
Daewoong Pharma Logo
Daewoong Pharma
KRX:069620
Watchlist
Price: 140 000 KRW 3.32% Market Closed
Market Cap: 1.6T KRW
Have any thoughts about
Daewoong Pharma?
Write Note

Wall Street
Price Targets

Price Targets Summary
Daewoong Pharma

Wall Street analysts forecast Daewoong Pharma stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Daewoong Pharma is 170 850 KRW with a low forecast of 151 500 KRW and a high forecast of 199 500 KRW.

Lowest
Price Target
151 500 KRW
8% Upside
Average
Price Target
170 850 KRW
22% Upside
Highest
Price Target
199 500 KRW
43% Upside
Daewoong Pharma Competitors:
Price Targets
MNMD
Mind Medicine (MindMed) Inc
381% Upside
PFE
Pfizer Inc
19% Upside
PPLPHARMA
Piramal Pharma Ltd
6% Downside
300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
13% Upside
LAURUSLABS
Laurus Labs Ltd
8% Downside
NWRN
Newron Pharmaceuticals SpA
90% Upside

Revenue
Forecast

Revenue Estimate
Daewoong Pharma

For the last 8 years the compound annual growth rate for Daewoong Pharma's revenue is 6%. The projected CAGR for the next 3 years is 4%.

6%
Past Growth
4%
Estimated Growth
Estimates Accuracy
4%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Daewoong Pharma

For the last 8 years the compound annual growth rate for Daewoong Pharma's operating income is 14%. The projected CAGR for the next 3 years is 14%.

14%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Net Income
Forecast

Net Income Estimate
Daewoong Pharma

For the last 8 years the compound annual growth rate for Daewoong Pharma's net income is 14%. The projected CAGR for the next 3 years is 2%.

14%
Past Growth
2%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Daewoong Pharma's stock price target?
Price Target
170 850 KRW

According to Wall Street analysts, the average 1-year price target for Daewoong Pharma is 170 850 KRW with a low forecast of 151 500 KRW and a high forecast of 199 500 KRW.

What is Daewoong Pharma's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Daewoong Pharma's revenue is 6%. The projected CAGR for the next 3 years is 4%.

What is Daewoong Pharma's Operating Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Daewoong Pharma's operating income is 14%. The projected CAGR for the next 3 years is 14%.

What is Daewoong Pharma's Net Income forecast?
Projected CAGR
2%

For the last 8 years the compound annual growth rate for Daewoong Pharma's net income is 14%. The projected CAGR for the next 3 years is 2%.

Back to Top